From question to insight in hours, not weeks.
nQuorate is a simulation platform hosting thousands of pre-built digital HCP personas. Built for Brand and Insights teams to test early stage TPPs, messages, and concepts — at a fraction of the time and cost of traditional fieldwork.
Study
TPP Testing — 1L non-targetable mNSCLC
Panel
316 HCPs
LIKELIHOOD TO PRESCRIBE (T2B%)
% rating 4 or 5 on a 1–5 scale for eligible 1L mNSCLC patients
HCP verbatim
Why
“Product X’s median PFS advantage and the q3w dosing are what would tip me toward it in a 1L decision.”
— Medical Oncologist · Community · US
“Product Y’s tolerability profile gives me more flexibility with frail patients — for 1L decisions, that nuance matters.”
— Medical Oncologist · Academic · US
“In community practice, q3w dosing means fewer chair days — that operational difference shapes my routine choice as much as efficacy data.”
— Medical Oncologist · Community · US
Study
Message Testing — Severe Uncontrolled Asthma
Panel
408 HCPs
Most motivating message (% selected)
Single-select among five tested messages
HCP verbatim
Why
“Exacerbations are what land my patients in the ED — anything that meaningfully reduces them is the message that moves me.”
— Pulmonologist · Academic · US
“M3 resonates with my atopic SUA patients — they track their FEV1 closely and want to see measurable lung function gains.”
— Allergist · Academic · US
Study
Core Visual Aid Testing — Rheumatoid Arthritis
Panel
276 HCPs
% selecting page as most critical to story
Five-page detail aid, rank-and-react methodology
HCP verbatim
Why
“The efficacy page is where I decide whether to keep listening — if those numbers don’t hold up, the rest of the conversation doesn’t matter.”
— Rheumatologist · Academic · US
“I find myself flipping back to the MOA page for new mechanisms — for JAKs especially, that grounding shapes how I read everything that follows.”
— Rheumatologist · Community · US
How it works
Three steps from question to insight.
-
01 Step
Choose your panel
Select from thousands of HCP personas built on published research, real-world data, and proprietary modeling. Filter on demographics, behavioural or attitudinal traits to select the relevant panel for your study.
Panel
Selected316 HCPsMedical Oncologist US 3+ years+291 more matching personas in panel
-
02 Step
Design your study
Select from a library of pre-built study templates, or describe your objective and let AI agents draft a custom questionnaire following life science market research conventions.
ALibraryUse a pre-defined template
TPP
Testing
Message
Testing
Concept
Testing
- Motivation to Rx
- Clarity of Message
- Believability of Claim
OrBAI agentsAuthor a custom questionnaire
“Test 5 message frames for SUA against community + academic pulmonologists, with a follow-up on OCS sparing.”Drafting questionnaire — 5 messages, T2B + verbatims -
03 Step
Get decision-ready insights
Receive comparative analyses, key drivers, and presentation-ready findings within hours. Ask follow-up questions against the same panel, test alternatives, and run what-if scenarios — without commissioning a new study.
Insights · Message Testing
ExportMost motivating
M1 · 31%
M131%M214%M323%M418%M514%62%Top driver segment
Academic pulmonologists
T2B lift +18 pts vs. community
Why M1 won
% of HCPs citing
- ED admissions are top concern73%
- Patient-actionable metric58%
- Aligns with GINA guideline framing41%
M3M1+M3Recommendation
Test a hybrid M1 + M3 variant
Tighter FEV1 framing projected to lift T2B
- ED admissions are top concern
Use cases
Pre-built study templates for common research questions.
Each template is pre-configured with instrument design and output structure — adapted from established market research methodologies.
Target Product Profile Testing
Stress-test claims, dosing, and positioning against HCP expectations before committing to a TPP direction.
Indicate your likelihood to prescribe Product X for eligible 1L mNSCLC patients.
Core Visual Aid Testing
Rank-and-react testing of detail aid pages — find your narrative anchor and the page that closes the prescribing decision.
Rank these pages in order of most motivating to least.
P1
P2
P3
P4
P5
Message Testing
Compare message frames head-to-head, identify which claims move likelihood to prescribe, and stress-test alternate framings.
Select the message most motivating to prescribe.
- M1Reduces annual exacerbations vs. SOC
- M2Reduces oral corticosteroid burden
- M3Improves FEV1 in 4 weeks
FAQ
Frequently Asked Questions
-
Each persona is constructed from a foundation of past primary market research (anonymized and aggregated) combined with public clinical, prescribing, and behavioral signals. We do not impersonate individual physicians — personas represent statistically grounded behavioral archetypes within a specialty, geography, and practice setting.
-
nQuorate is designed for the early, iterative, directional studies where speed matters most — concept testing, message refinement, TPP stress-testing, segmentation hypotheses. For decisions requiring statistically powered sample sizes against regulators or payers, traditional fielded studies remain the gold standard. Many of our customers use nQuorate to converge fast, then field the final cut.
-
We benchmark persona responses against held-out fielded studies and track directional accuracy over time. Each study includes confidence indicators that flag when a question lies outside the persona’s validated response space.
-
Oncology, cardiovascular, immunology, neurology, metabolic, and rare disease are live, with new areas onboarded as we add design partners. Coverage spans US and EU5 across academic, community, and IDN settings.
-
We do not store HCP PII. The platform is built with Fortune 500 procurement, legal, and IT review in mind — including data residency, SSO, audit logging, and signed master agreements. Compliance documentation is available under NDA.
-
We’re onboarding a small group of design partners at preferred pricing. Get in touch and we’ll walk you through plans tailored to your team’s research volume.
Design Partner Program
Help shape the platform.
nQuorate is in active development. We’re inviting brand and insights teams to pilot the panel on live research questions.